James Lalonde Insider Trading $CDXS CODEXIS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James Lalonde.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James Lalonde. James Lalonde is SVP, R&D in CODEXIS INC ($CDXS).
James Lalonde in CODEXIS, INC.
Trading Symbol: CDXSIndustry: INDUSTRIAL ORGANIC CHEMICALS [2860]
Position of James Lalonde: SVP, R&D
Holdings: 151,023 shares
Current Value: $672,052
Latest Transaction: May 15 2019
$CDXS Market Capitalization: $179.31M
$CDXS Previous Close: $4.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James Lalonde in CODEXIS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 15 2019 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | M | 7.46 | 2,378 | 17,740 | 0 | |
May 15 2019 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | M | 7.46 | 17,621 | 131,453 | 2,378 | |
May 15 2019 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Sell | S | 18.95 | 2,378 | 45,060 | 133,402 | 135.8 K to 133.4 K (-1.75 %) |
May 15 2019 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Buy | M | 7.46 | 2,378 | 17,740 | 135,780 | 133.4 K to 135.8 K (+1.78 %) |
May 15 2019 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Sell | S | 18.61 | 17,621 | 327,955 | 133,402 | 151 K to 133.4 K (-11.67 %) |
May 15 2019 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Buy | M | 7.46 | 17,621 | 131,453 | 151,023 | 133.4 K to 151 K (+13.21 %) |
Feb 22 2019 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | A | 21.80 | 23,000 | 501,400 | 23,000 | |
Feb 22 2019 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | A | 8.95 | 100,300 | 897,685 | 100,300 | |
Sep 06 2018 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Sell | S | 17.35 | 12,381 | 214,849 | 164,770 | 177.2 K to 164.8 K (-6.99 %) |
Sep 06 2018 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Sell | S | 17.16 | 17,915 | 307,348 | 177,151 | 195.1 K to 177.2 K (-9.18 %) |
Jul 18 2018 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Sell | S | 15.27 | 7,500 | 114,553 | 195,066 | 202.6 K to 195.1 K (-3.70 %) |
Jul 18 2018 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Sell | S | 15.53 | 7,500 | 116,457 | 202,566 | 210.1 K to 202.6 K (-3.57 %) |
May 15 2018 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Sell | S | 12.90 | 10,000 | 129,030 | 210,066 | 220.1 K to 210.1 K (-4.54 %) |
May 15 2018 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Sell | S | 13.09 | 10,000 | 130,900 | 220,066 | 230.1 K to 220.1 K (-4.35 %) |
Mar 07 2018 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Payment of Exercise | F | 10.90 | 11,920 | 129,928 | 230,066 | 242 K to 230.1 K (-4.93 %) |
Feb 22 2018 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | A | 9.05 | 55,000 | 497,750 | 55,000 | |
Feb 07 2018 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | A | 4.60 | 147,620 | 679,052 | 147,620 | |
Mar 07 2017 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Payment of Exercise | F | 4.15 | 20,630 | 85,615 | 241,986 | 262.6 K to 242 K (-7.86 %) |
Feb 14 2017 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Payment of Exercise | F | 4.35 | 2,404 | 10,457 | 262,616 | 265 K to 262.6 K (-0.91 %) |
Feb 14 2017 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Grant | A | 0.00 | 66,881 | 0 | 265,020 | 198.1 K to 265 K (+33.75 %) |
Feb 07 2017 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | A | 4.60 | 110,000 | 506,000 | 110,000 | |
Jan 09 2017 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | M | 2.45 | 6,666 | 16,332 | 0 | |
Jan 09 2017 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Buy | M | 2.45 | 6,666 | 16,332 | 198,139 | 191.5 K to 198.1 K (+3.48 %) |
Mar 08 2016 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Payment of Exercise | F | 3.66 | 12,478 | 45,669 | 191,473 | 204 K to 191.5 K (-6.12 %) |
Feb 23 2016 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | A | 4.10 | 77,000 | 315,700 | 77,000 | |
Feb 23 2016 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Grant | A | 0.00 | 39,904 | 0 | 203,951 | 164 K to 204 K (+24.32 %) |
Feb 12 2016 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Payment of Exercise | F | 3.93 | 3,964 | 15,579 | 164,047 | 168 K to 164 K (-2.36 %) |
Nov 12 2015 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | M | 1.05 | 16,391 | 17,211 | 0 | |
Nov 12 2015 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | M | 1.05 | 10,275 | 10,789 | 16,391 | |
Nov 12 2015 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Sell | S | 3.52 | 5,805 | 20,431 | 168,011 | 173.8 K to 168 K (-3.34 %) |
Nov 12 2015 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Buy | M | 1.05 | 16,391 | 17,211 | 173,816 | 157.4 K to 173.8 K (+10.41 %) |
Nov 12 2015 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Sell | S | 3.52 | 3,636 | 12,802 | 157,425 | 161.1 K to 157.4 K (-2.26 %) |
Nov 12 2015 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Buy | M | 1.05 | 10,275 | 10,789 | 161,061 | 150.8 K to 161.1 K (+6.81 %) |
May 12 2015 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Payment of Exercise | F | 4.26 | 13,153 | 56,032 | 150,786 | 163.9 K to 150.8 K (-8.02 %) |
Mar 09 2015 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Payment of Exercise | F | 3.99 | 4,999 | 19,946 | 163,939 | 168.9 K to 163.9 K (-2.96 %) |
Feb 12 2015 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | A | 3.39 | 70,000 | 237,300 | 70,000 | |
Feb 12 2015 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Grant | A | 0.00 | 23,850 | 0 | 168,938 | 145.1 K to 168.9 K (+16.44 %) |
Feb 12 2015 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Payment of Exercise | F | 3.59 | 5,154 | 18,503 | 145,088 | 150.2 K to 145.1 K (-3.43 %) |
Aug 12 2014 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Payment of Exercise | F | 2.13 | 12,331 | 26,302 | 150,242 | 162.6 K to 150.2 K (-7.58 %) |
Jul 02 2014 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | M | 0.68 | 27,350 | 18,598 | 0 | |
Jul 02 2014 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Buy | M | 0.68 | 27,350 | 18,598 | 162,573 | 135.2 K to 162.6 K (+20.23 %) |
Mar 12 2014 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Payment of Exercise | F | 1.99 | 6,583 | 13,100 | 135,223 | 141.8 K to 135.2 K (-4.64 %) |
Feb 26 2014 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Option Exercise | A | 1.97 | 75,000 | 147,750 | 75,000 | |
Feb 13 2014 | CDXS | CODEXIS INC | Lalonde James | SVP, R&D | Payment of Exercise | F | 1.79 | 5,154 | 9,226 | 141,806 | 136.7 K to 141.8 K (+3.77 %) |
Page: 1